A Retrospective Comparative Study on Median Time to Sputum Culture Conversion in Multi-Drug Resistant Pulmonary Tuberculosis Patients in Pastoral and Non-Pastoral Settings in Southeast Oromia, Ethiopia

References

• World Health Organization. Guidance for the surveillance of drug resistance in tuberculosis. World Health Organization; 2020.
   Google Scholar
• World Health Organization. Global tuberculosis report 2020. World Health Organization; 2020.
   Google Scholar
• Federal Ministry of Health Ethiopia. Guidelines for clinical and programmatic management of TB, TB/ HIV,DR-TB and leprosy in Ethiopia; 2021.
   Google Scholar
• Ki-moon B. Building a tuberculosis-free world on a foundation of universal health coverage. Lancet. 2019;393:1268–1270. doi:10.1016/S0140-6736(19)30433-730904268
   PubMed Web of Science ®Google Scholar
• World Health Organization. End TB strategy. Global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva; 2014.
   Google Scholar
• Federal Ministry of Health Ethiopia. Guidelines for TB, DR-TB and LEPROSY in Ethiopia, sixth edition; 2017.
   Google Scholar
• Kebede A, Beyene D, Yenew B, et al. Monitoring quality indicators for the Xpert MTB/RIF molecular assay in Ethiopia. PLoS One. 2019;14(11):e0225205. doi:10.1371/journal.pone.022520531714934
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment; 2019.
   Google Scholar
• Liu Q, Lu P, Martinez L, et al. Factors affecting time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis in China. BMC Infect Dis. 2018;18:114. doi:10.1186/s12879-018-3021-029510666
   PubMed Web of Science ®Google Scholar
• Russkikh A, Korotych O, Sereda Y, et al. Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018–2019 in the Russian Federation: an observational cohort study. Monaldi Arch Chest Dis. 2021;91. doi:10.4081/monaldi.2021.1678
   Web of Science ®Google Scholar
• Velayutham B, Nair D, Kannan T, et al. Factors associated with sputum culture conversion in multi-drug- resistant pulmonary tuberculosis. Int J Tuberc Lung Dis. 2016;20:1671–1676. doi:10.5588/ijtld.16.009627931345
   PubMed Web of Science ®Google Scholar
• Diktanas S, Korotych O, Sereda Y, et al. Factors associated with time to sputum culture conversion of rifampicin-resistant tuberculosis patients in Klaipeda, Lithuania in 2016–2019: a cohort study. Monaldi Arch Chest Dis. 2021;91. doi:10.4081/monaldi.2021.1675
   Web of Science ®Google Scholar
• Kapata N, Chanda-Kapata P, Michelo C. The social determinants of tuberculosis and their association with TB-HIV co-infection in Lusaka, Zambia. Med J Zambia. 2013;40:7.
   Google Scholar
• Hargreaves JR, Boccia D, Evans CA, et al. The social determinants of tuberculosis: from evidence to action. Am J Public Health. 2011;101:654–662. doi:10.2105/AJPH.2010.19950521330583
   PubMed Web of Science ®Google Scholar
• Duarte R, Lönnroth K, Carvalho C, et al. Tuberculosis, social determinants and co-morbidities (including HIV). Pulmonology. 2018;24:115–119. doi:10.1016/j.rppnen.2017.11.00329275968
   PubMed Web of Science ®Google Scholar
• Megerso A, Deyessa N, Jarso G, Tezera R, Worku A. Exploring community tuberculosis program in the pastoralist setting of Ethiopia: a qualitative study of community health workers’ perspectives in Borena Zone, Oromia Region. BMC Health Serv Res. 2021;21:632. doi:10.1186/s12913-021-06683-y34210297
   PubMed Web of Science ®Google Scholar
• Megerso A, Deyessa N, Jarso G, Worku A. Lived experiences of tuberculosis patients and their implications for early tuberculosis case identification and management in pastoralist community setting: a qualitative study in Borena zone, Oromia region of Ethiopia. BMC Health Serv Res. 2020;20:933. doi:10.1186/s12913-020-05787-133036606
   PubMed Web of Science ®Google Scholar
• Dupont WD, Plummer WD. Power and sample size calculations: a review and computer program. Control Clin Trials. 1990;11(2):116–128. doi:10.1016/0197-2456(90)90005-M2161310
   PubMedGoogle Scholar
• Halabi S, Singh B. Sample size determination for comparing several survival curves with unequal allocations. Stat Med. 2004;23:1793–1815. doi:10.1002/sim.177115160409
   PubMed Web of Science ®Google Scholar
• Shibabaw A, Gelaw B, Wang S-H, Tessema B. Time to sputum smear and culture conversions in multi-drug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia. PLoS One. 2018;13:e0198080. doi:10.1371/journal.pone.019808029944658
   PubMed Web of Science ®Google Scholar
• IBM SPSS Statistics. IBM SPSS statistics for windows, version 26.0. Armonk, NY: IBM Corp.; 2019.
   Google Scholar
• Center for Disease Control. Epi infoTM 7 user guide for version 7.2. 645; 2016.
   Google Scholar
• Magee MJ, Kempker RR, Kipiani M, et al. Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia. PLoS One. 2014;9:e94890. doi:10.1371/journal.pone.009489024736471
   PubMed Web of Science ®Google Scholar
• Yihunie Akalu T, Muchie KF, Alemu Gelaye K, Munderloh UG. Time to sputum culture conversion and its determinants among multi-drug resistant tuberculosis patients at public hospitals of the Amhara Regional State: a multicenter retrospective follow up study. PLoS One. 2018;13:e0199320. doi:10.1371/journal.pone.019932029927980
   PubMed Web of Science ®Google Scholar
• Martinson NA, Ncha R, Variava E, Otwombe K, Kawonga M. Predictors of time to sputum culture conversion in multi-drug-resistant tuberculosis and extensively drug-resistant tuberculosis in patients at Tshepong-Klerksdorp Hospital. South Afr J Infect Dis. 2019;34:1–8.
   Web of Science ®Google Scholar
• Tekalegn Y, Woldeyohannes D, Assefa T, Aman R, Sahiledengle B. Predictors of time to sputum culture conversion among drug-resistant tuberculosis patients in Oromia region hospitals, Ethiopia. Infect Drug Resist. 2020;13:2547–2556. doi:10.2147/IDR.S25087832821129
   PubMed Web of Science ®Google Scholar
• Tierney DB, Franke MF, Becerra MC, et al. Time to culture conversion and regimen composition in multidrug-resistant tuberculosis treatment. PLoS One. 2014;9:e108035. doi:10.1371/journal.pone.010803525238411
   PubMed Web of Science ®Google Scholar
• Assemie MA, Alene M, Petrucka P, Leshargie CT, Ketema DB. Time to sputum culture conversion and its associated factors among multidrug-resistant tuberculosis patients in Eastern Africa: a systematic review and meta-analysis. Int J Infect Dis. 2020;98:230–236. doi:10.1016/j.ijid.2020.06.02932535296
   PubMed Web of Science ®Google Scholar
• Park H-O, Kim SH, Moon SH, et al. Association between body mass index and sputum culture conversion among South Korean patients with multidrug resistant tuberculosis in a tuberculosis referral hospital. Infect Chemother. 2016;48:317. doi:10.3947/ic.2016.48.4.31727883374
   PubMedGoogle Scholar
• Putri FA, Burhan E, Nawas A, et al. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia. Int J Tuberculosis Lung Dis. 2014;18(5):564–570. doi:10.5588/ijtld.13.0602
   PubMed Web of Science ®Google Scholar
• Salindri AD, Kipiani M, Kempker RR, et al. Diabetes reduces the rate of sputum culture conversion in patients with newly diagnosed multidrug-resistant tuberculosis. Open Forum Infect Dis. 2016;3:ofw126. doi:10.1093/ofid/ofw12627419188
   PubMed Web of Science ®Google Scholar
• Lu P, Liu Q, Martinez L, et al. Time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis: a prospective cohort study from urban China. Eur Respir J. 2017;49:1601558. doi:10.1183/13993003.01558-201628331033
   PubMed Web of Science ®Google Scholar